DR. DEEPA BAI JAGTAP M.D. NPI 1629190095

NPI Details

DR. Deepa Bai Jagtap, M.D. is a hematology and oncology internal medicine in Royal Oak, MI with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Deepa Bai Jagtap, M.D. NPI is 1629190095. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

3577 W 13 MILE RD
SUITE 103
ROYAL OAK, MI
ZIP 48073-710
Phone: (248) 288-4500
Fax: (248) 288-0450

The NPI 1629190095 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Liver function blood test panel (HCPCS:80076)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Magnesium level (HCPCS:83735)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Unclassified drugs (HCPCS:J3490)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 4/4/2007 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.